General MedicationsORALStandard
PONSTEL
MEFENAMIC ACID
Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PONSTEL is listed in Drugs@FDA under application 015034 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MEFENAMIC ACID Form and strength CAPSULE;ORAL - 250MG Sponsor AVION PHARMS Submission history Latest submission status date: 2025-12-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview PONSTEL is listed in Drugs@FDA under application 015034 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MEFENAMIC ACID Form and strength CAPSULE;ORAL - 250MG Sponsor AVION PHARMS Submission history Latest submission status date: 2025-12-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.